Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 436 AL 450

Decreased coherence and functional connectivity of electroencephalograph in Alzheimer's disease

Wang R, Wang J, Yu H, Wei X, Yang C, Deng B.

Chaos. 2014 Sep;24(3):033136. doi: 10.1063/1.4896095.

Does insulin therapy for type 1 diabetes mellitus protect against Alzheimer's disease?

Rdzak GM, Abdelghany O.

Pharmacotherapy. 2014 Dec;34(12):1317-23. doi: 10.1002/phar.1494. Epub 2014 Oct 3.

Alzheimer's disease and epigenetic diet

Sezgin Z, Dincer Y.

Neurochem Int. 2014 Dec;78:105-16. doi: 10.1016/j.neuint.2014.09.012. Epub 2014 Oct 5.

Advances in recent patent and clinical trial drug development for Alzheimer's disease

Liu H, Wang L, Su W, Xie XQ.

Pharm Pat Anal. 2014 Jul;3(4):429-47. doi: 10.4155/ppa.14.22.

NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

Lawlor B, Kennelly S, O'Dwyer S, Cregg F, Walsh C, Coen R, Kenny RA, Howard R, Murphy C, Adams J, Daly L, Segurado R, Gaynor S, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Wallin A, Borjesson A, Molloy W, Tsolaki M, Olde Rikkert M.

BMJ Open. 2014 Oct 9;4(10):e006364. doi: 10.1136/bmjopen-2014-006364.

A critical analysis of the 'amyloid cascade hypothesis'

Armstrong RA.

Folia Neuropathol. 2014;52(3):211-25.

Genetics of Alzheimer's disease

Chouraki V, Seshadri S.

Adv Genet. 2014;87:245-94. doi: 10.1016/B978-0-12-800149-3.00005-6.

Dietary polyphenols for treatment of Alzheimer's disease--future research and development

Malar DS, Devi KP.

Curr Pharm Biotechnol. 2014;15(4):330-42. doi: 10.2174/1389201015666140813122703.

Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues

Obulesu M, Lakshmi MJ.

Neurochem Res. 2014 Dec;39(12):2301-12. doi: 10.1007/s11064-014-1454-4. Epub 2014 Oct 17.

Quantifying the eating abnormalities in frontotemporal dementia

Ahmed RM, Irish M, Kam J, van Keizerswaard J, Bartley L, Samaras K, Hodges JR, Piguet O.

JAMA Neurol. 2014 Dec;71(12):1540-6. doi: 10.1001/jamaneurol.2014.1931.

[Clinically validated molecular biomarkers of neurodegenerative dementia]

Wiltfang J.

Nervenarzt. 2014 Nov;85(11):1372-81. doi: 10.1007/s00115-014-4086-7.

The emerging link between O-GlcNAc and Alzheimer disease

Zhu Y, Shan X, Yuzwa SA, Vocadlo DJ.

J Biol Chem. 2014 Dec 12;289(50):34472-81. doi: 10.1074/jbc.R114.601351. Epub 2014 Oct 21.

Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation

Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S; Alzheimer's Disease Neuroimaging Initiative; Fagan AM, Holtzman DM, Morris JC, Goate AM.

PLoS Genet. 2014 Oct 23;10(10):e1004758. doi: 10.1371/journal.pgen.1004758. eCollection 2014 Oct.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias